EANS-News: Lobeck Medical AG / Lobeck Medical AG successfully completed fiscal year 2008 - Swiss Medical Company increased sales by over 60%

Lobeck Medical AG generated positive result in the fiscal year 2008
and rose revenue to over 60% – Blood glucose meter Sapphire
successfully placed on the market - New markets gained for MediSmart®
of Switzerland

--------------------------------------------------------------------------------
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
the content of this announcement.
--------------------------------------------------------------------------------

companies/finances/stock market/medical technology

Frick (euro adhoc) - Frick, April 1st, 2009 - Lobeck Medical AG, a
Swiss medical technology company listed in the Open Market of the
Frankfurt stock exchange, completed the fiscal year 2008 with a
turnover of almost CHF 3.3 million and an EBIT of CHF 304,000. The
Revenue grew by more than 60% compared to the previous year. "Thus we
were able to close with profit for the third time in succession",
explains Andreas Dornbierer, president of Lobeck Medical AG. The
equity of the Swiss medical technology company added up to CHF
998,000 per December 31st, 2008 (equity ratio 61%).

Under the brand name MediSmart® of Switzerland the Lobeck Medical AG
develops and distributes user friendly product solutions for the
medical diagnostics market with focus on diabetes (glucometer) and
home test products. The rapid tests in the field of In Vitro
Diagnostics (IVD) include, for example, early pregnancy tests and
colorectal occult blood tests. To expedite the global expansion of
the product lines of MediSmart of Switzerland®, the Lobeck Medical AG
has recourse to a dense international distribution network which the
company has built and established over the last few years.

"In fiscal year 2008, we were able to gain new markets for blood
glucose meters as well as In Vitro Diagnostics (IVD)", says Andreas
Dornbierer. "Our newest blood glucose meter Sapphire has been placed
in the market very successfully. Another highlight is our
collaboration with Lilly, one of the world's leading pharmaceutical
companies, as distributor for glucose measuring devices in Greece."

The Lobeck Medical AG could continuously increase revenues for IVD
home test products in various countries in the reporting year 2008.
"In 2009 we will extend our existing product lines to continue the
strong growth rate of the last few years. We cannot name concrete the
figures yet because apart from the internal growth we have to
consider a potential takeover or an in-licensing agreement of new
products as well. Due to our international expansion strategy we
expect significant growth in sales of our diabetes and home test
products however."

About the company: The Lobeck Medical AG develops and distributes
user friendly product solutions for the medical diagnostics market
with focus on diabetes (glucometer) and home test products. With
sales offices in over 30 countries the company has established a wide
international distribution network to market new products
developments under the protected brand name Medi¬Smart® of
Switzerland all over the world. The Lobeck Medical AG is a Swiss
company manufacturing high quality blood glucose meters in
Switzerland to be distributed worldwide under its own brand name.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Lobeck Medical AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Press contact:

Kristina Ducke

fr financial relations gmbh

Phone: +49/ (0) 69 95 90 83 -15

Fax: +49/ (0) 69 95 90 83 -99

Email: k.ducke@financial-relations.de

Branche: Healthcare Providers
ISIN: CH0025477065
WKN: A0MR20
Börsen: Börse Frankfurt / Open Market
Börse Berlin / free trade